Continuous low-dose cyclophosphamide (NSC-26271) therapy in advanced ovarian cancer.
D000328:Adult; D000368:Aged; D002369:Castration; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011379:Prognosis; D013921:Thrombocytopenia / Q000139:chemically induced
D003520:Cyclophosphamide